Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?
Joyce W Y ChanIvan C H SiuAliss T C ChangMolly S C LiRainbow W H LauTony S K MokCalvin Sze-Hang NgPublished in: Cancers (2023)
The demand for parenchyma-sparing local therapies for lung cancer is rising owing to an increasing incidence of multifocal lung cancers and patients who are unfit for surgery. With the latest evidence of the efficacy of lung cancer screening, more premalignant or early-stage lung cancers are being discovered and the paradigm has shifted from treatment to prevention. Transbronchial therapy is an important armamentarium in the local treatment of lung cancers, with microwave ablation being the most promising based on early to midterm results. Adjuncts to improve transbronchial ablation efficiency and accuracy include mobile C-arm platforms, software to correct for the CT-to-body divergence, metal-containing nanoparticles, and robotic bronchoscopy. Other forms of energy including steam vapor therapy and pulse electric field are under intensive investigation.
Keyphrases
- early stage
- ultrasound guided
- end stage renal disease
- computed tomography
- ejection fraction
- chronic kidney disease
- newly diagnosed
- robot assisted
- risk factors
- magnetic resonance imaging
- squamous cell carcinoma
- peritoneal dialysis
- radiation therapy
- young adults
- combination therapy
- coronary artery bypass
- cell therapy
- patient reported